PalanerFree on the App Store
Get
Reprotech and the Next Era of Women’s Health: A FemTech Talk with Pranam Chatterjee
WorkFree

Reprotech and the Next Era of Women’s Health: A FemTech Talk with Pranam Chatterjee

Tuesday 17 November 2026, 18:00Venue time (Lisbon)
maze impactDirections
FreeTickets sold by luma.com
Book · Freevia luma.com
Add to calendar

Downloads an .ics file · Times are in Europe/Lisbon · Google Calendar

Two days of hormone injections instead of fourteen. Eggs matured in a dish by engineered cells. A first baby born in Lima in December 2024. A Phase 3 trial under way in the US.

That is the ambition behind Fertilo, the lead product of Gameto, a biotechnology company that just got aquired by Ferring Pharmaceuticals for $1.38 billion.

On 17 November, we will have the pleasure of welcoming Pranam Chatterjee, one of the bright minds behind that ambition, for an informal evening conversation.

The speaker

Pranam Chatterjee is a cofounder and adviser of Gameto and Distinguished Assistant Professor of Bioengineering and Computer and Information Science at the University of Pennsylvania. An MIT PhD, he trained with George Church’s group at Harvard, where the cell engineering behind Gameto was developed. Today his lab uses generative AI to design proteins for infertility, rare neurodegenerative diseases and paediatric sarcomas.

FemTech Talks - The evening

Expect an open conversation about reproductive biotechnology, fertility and women’s health: the science, the path from lab to clinic, what investors and regulators need to see, and how innovation like this could reach Portugal.

Welcome from António Miguel,with a look at Maze’s investment in science based healthcare companies and FemTech Portugal

Inês Santos Silva on why funding women’s health research matters

Pranam Chatterjee on his work, followed by questions and open discussion

Who should comeResearchers, founders, investors, clinicians and anyone curious about where fertility and women’s health are heading.

A small room, direct access to the speaker and the chance to meet people building in this space.

Organised by

FemTech Portugal x Maze, with support from TejoMed and AthenaDAO.

FemTech Portugal is a non-profit association dedicated to accelerating women’s health innovation in Portugal. We bring together founders, healthcare professionals, researchers, investors, and advocates to connect, collaborate, and create a meaningful impact in women’s healthcare.

Our mission is to build a strong and inclusive ecosystem that empowers innovation, supports collaboration, and amplifies the voices shaping the future of FemTech in Portugal and beyond.

Maze is a Lisbon based impact investor, founded in 2013 by the Calouste Gulbenkian Foundation. Through venture capital funds, advisory services and acceleration programmes, it backs founders building science based healthcare and climate companies with social and environmental impact.

TejoMed is a membership based primary care clinic in Lisbon. Its family medicine doctors see fewer patients, which leaves more time for personalised and preventive care.

AthenaDAO is a community of researchers, funders and advocates working to advance women’s health research, education and funding. It sources, funds and incubates translational research, taking early science towards diagnostics, drugs and therapeutics.

Ask Palaner

Going to Reprotech and the Next Era of Women’s Health? Ask me anything about it.

I read the organiser's pages and answer in a few seconds.

Answers are AI-generated · Privacy